Ziff Davis
ZD
54.90
+0.13
+0.24%
Ziff Davis
US · ZD
#2818 by market cap
Listed 1970
54.90
+0.13
+0.24%
Live - 5344 symbols - heartbeat 480s ago
· 2026-10-08 08:24
Pre-market
55.48
+1.06%
After-hours
54.47
-0.78%
Overnight
54.90
0.00%
- Market cap
- 1.88B
- P/E (TTM)i
- 3.15
- P/Bi
- 0.84
- EPSi
- 1.15
- Div yieldi
- 0.00%
- 52W posi
- 85%
Reader sentiment
Are you bullish or bearish on ZD?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Weak
- Altman Z-Score is 1.76, below the 1.8 "distress zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +3.54% YoY
Margins
- Gross margin
- 85.76%
- Operating margin
- 12.62%
- Net margin
- 3.26%
Key ratios & quality
- Enterprise valuei
- 2.14B
- Altman Z-Scorei
- 1.76
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 1.21B | 1.05B | 1.16B | 1.42B | 1.39B | 1.36B | 1.40B | 1.45B |
| Gross profit | 1.01B | 863.13M | 980.43M | 1.23B | 1.21B | 1.18B | 1.20B | 1.24B |
| Selling & admin expenses | 713.57M | 730.26M | 784.94M | 949.83M | 672.65M | 683.09M | 723.16M | 753.35M |
| Research & development | 48.37M | 44.65M | 57.15M | 78.87M | 74.09M | 68.86M | 67.37M | 61.96M |
| Operating profit | 244.28M | 88.22M | 138.34M | 199.97M | 226.31M | 189.46M | 198.92M | 183.10M |
| Pretax profit | 177.59M | 54.82M | 78.35M | 351.35M | 131.15M | 74.97M | 93.19M | 80.75M |
| Tax | 44.76M | 13.76M | 38.35M | -14.20M | 57.96M | 24.14M | 41.37M | 25.45M |
| Net profit | 128.69M | 218.81M | 150.67M | 496.71M | 63.76M | 41.50M | 63.05M | 47.35M |
| Basic EPS | 3 | 5 | 3 | 11 | 1 | 1 | 1 | 1 |
| Diluted EPS | 2.59 | 4.39 | 3.18 | 10.37 | 1.36 | 0.89 | 1.42 | 1.15 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 272.82M | 294.80M | 363.71M | 406.71M | 267.64M | 286.74M |
| Gross profit | 232.42M | 254.14M | 310.56M | 349.45M | 223.32M | 241.03M |
| Selling & admin expenses | 155.57M | 175.84M | 191.83M | 191.26M | 161.88M | 169.67M |
| Research & development | 13.92M | 14.20M | 15.40M | 14.21M | 13.64M | 14.37M |
| Operating profit | 14.47M | 13.77M | 28.44M | 86.05M | 2.93M | 10.12M |
| Pretax profit | 6.80M | 9.12M | 9.14M | 19.90M | -3.28M | -51.08M |
| Tax | 3.62M | -69.00K | 12.78M | -204.00K | 2.64M | 941.00K |
| Net profit | 24.24M | 26.34M | -3.60M | 370.00K | 22.26M | 624.46M |
| Basic EPS | 1 | 1 | 0 | 0 | 1 | 17 |
| Diluted EPS | 0.57 | 0.63 | -0.09 | 0.01 | 0.59 | 17.16 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 460.33M | 886.89M | 622.84M | 1.30B | 1.08B | 1.19B | 1.27B | 1.37B |
| Cash & ST investments | 209.47M | 575.62M | 177.11M | 924.04M | 711.21M | 764.72M | 505.88M | 607.01M |
| Inventory | -- | -- | -- | -- | -- | -- | -- | -- |
| Total assets | 2.56B | 3.51B | 3.67B | 3.77B | 3.53B | 3.47B | 3.70B | 3.66B |
| Total current liabilities | 307.32M | 833.10M | 882.56M | 497.24M | 432.45M | 431.83M | 899.65M | 1.07B |
| Short-term debt | -- | 412.46M | 426.44M | 54.61M | -- | -- | -- | 148.69M |
| Long-term debt | 1.01B | 1.06B | 1.18B | 1.04B | 999.05M | 1.00B | 864.28M | 717.82M |
| Total liabilities | 1,525,086,000.00 | 2,194,654,000.00 | 2,454,313,000.00 | 1,802,548,000.00 | 1,640,659,000.00 | 1,578,024,000.00 | 1,893,452,000.00 | 1,909,731,000.00 |
| Total equity | 1.04B | 1.31B | 1.21B | 1.97B | 1.89B | 1.89B | 1.81B | 1.75B |
| Retained earnings | 769.58M | 891.53M | 809.11M | 1.52B | 1.54B | 1.49B | 1.40B | 1.34B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 1.07B | 1.10B | 1.12B | 1.37B | 1.44B | 2.08B |
| Cash & ST investments | 431.01M | 457.26M | 503.37M | 607.01M | 519.72M | 1.61B |
| Inventory | -- | -- | -- | -- | -- | -- |
| Total assets | 3.52B | 3.52B | 3.48B | 3.66B | 3.39B | 4.00B |
| Total current liabilities | 704.77M | 692.84M | 698.01M | 1.07B | 863.72M | 963.33M |
| Short-term debt | -- | -- | -- | 148.69M | 148.81M | 148.94M |
| Long-term debt | 864.83M | 865.38M | 865.94M | 717.82M | 718.26M | 718.70M |
| Total liabilities | 1,694,510,000.00 | 1,676,751,000.00 | 1,678,025,000.00 | 1,909,731,000.00 | 1,672,777,000.00 | 1,760,569,000.00 |
| Total equity | 1.82B | 1.84B | 1.80B | 1.75B | 1.72B | 2.24B |
| Retained earnings | 1.41B | 1.41B | 1.37B | 1.34B | 1.33B | 1.87B |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 401.33M | 412.54M | 480.08M | 516.54M | 336.44M | 319.96M | 390.32M | 407.07M |
| Depreciation & amortization | 187.17M | 232.03M | 228.74M | 258.30M | 233.40M | 236.97M | 211.92M | 228.69M |
| Free cash flow | 344.28M | 341.91M | 384.41M | 402.80M | 230.29M | 211.23M | 283.68M | 287.87M |
| Dividends paid | -82.57M | -43.92M | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | -45.56M | -15.53M | -274.04M | -78.33M | -78.29M | -108.53M | -185.18M | -173.79M |
| Ending cash balance | 209.47M | 575.62M | 242.65M | 694.84M | 652.79M | 737.61M | 505.88M | 607.01M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | 20.61M | 57.07M | 138.30M | 191.08M | 29.95M | 88.96M |
| Depreciation & amortization | 55.83M | 57.61M | 57.32M | 57.93M | 49.78M | 46.87M |
| Free cash flow | -5.01M | 26.94M | 108.16M | 157.77M | -3.17M | 53.96M |
| Dividends paid | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | -34.90M | -33.93M | -44.39M | -60.57M | -51.59M | -121.46M |
| Ending cash balance | 431.01M | 457.26M | 503.37M | 607.01M | 545.82M | 1.61B |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 12.33 | 18.35 | 11.90 | 31.23 | 3.30 | 2.19 | 3.40 | 2.66 |
| ROA %i | 5.06 | 7.10 | 4.18 | 13.35 | 1.75 | 1.19 | 1.76 | 1.29 |
| ROIC %i | 8.51 | 10.39 | 8.36 | 18.12 | 3.04 | 1.90 | 2.66 | 2.39 |
| 5-year avg ROE %i | 14.91 | 15.44 | 14.75 | 17.67 | 15.48 | 13.46 | 10.41 | 8.56 |
| EBIT margin %i | 19.84 | 19.62 | 24.33 | 29.88 | 11.86 | 6.97 | 7.65 | 7.35 |
| FCF / sales %i | 28.52 | 24.92 | 25.81 | 28.43 | 16.55 | 15.49 | 20.24 | 19.84 |
| Current ratioi | 1.50 | 1.06 | 0.71 | 2.62 | 2.51 | 2.76 | 1.41 | 1.27 |
| Quick ratioi | 1.40 | 1.01 | 0.55 | 2.49 | 2.35 | 2.55 | 1.30 | 1.19 |
| Debt / assetsi | 39.56 | 45.05 | 45.90 | 28.93 | 28.28 | 28.85 | 23.33 | 23.65 |
| LT debt / equityi | 97.82 | 89.00 | 103.70 | 52.65 | 52.79 | 52.90 | 47.73 | 40.93 |
| Interest coveragei | 3.86 | 3.87 | 2.75 | 5.88 | 4.88 | 4.74 | 7.66 | 4.12 |
| Revenue CAGR (3Y) %i | 18.76 | 6.31 | 1.21 | 5.48 | 9.81 | 5.58 | -0.36 | 1.42 |
| Net income CAGR (3Y) %i | -1.25 | 12.80 | 2.62 | 56.86 | -33.70 | -34.93 | -49.74 | -9.44 |
| FCF CAGR (3Y) %i | 17.86 | 10.51 | 19.98 | 5.37 | -12.34 | -18.09 | -11.03 | 7.72 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | 4.15 | 3.56 | 6.26 | 2.66 | 2.56 | 31.54 |
| ROA %i | 2.13 | 1.84 | 3.22 | 1.29 | 1.31 | 17.12 |
| ROIC %i | 3.28 | 3.02 | 4.89 | 2.39 | 2.31 | 22.11 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 8.35 | 7.83 | 11.04 | 7.35 | 6.73 | 2.52 |
| FCF / sales %i | 16.33 | 16.11 | 17.92 | 19.84 | 20.03 | 22.03 |
| Current ratioi | 1.52 | 1.59 | 1.61 | 1.27 | 1.66 | 2.16 |
| Quick ratioi | 1.35 | 1.41 | 1.40 | 1.19 | 1.06 | 2.10 |
| Debt / assetsi | 24.60 | 24.59 | 24.91 | 23.65 | 25.54 | 21.70 |
| LT debt / equityi | 47.48 | 46.96 | 48.14 | 40.93 | 41.72 | 32.12 |
| Interest coveragei | 6.44 | 4.92 | 6.30 | 4.12 | 3.66 | 1.41 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Diversified
- Health & Wellness is the largest reported line at 33.01% of revenue, across 4 reported segments.
- No single line clears half of revenue; Technology & Shopping is next at 26.77%, spreading the business across more than one real driver.
Revenue breakdown most recent period
Business
Health & Wellness33.01%
Technology & Shopping26.77%
Cybersecurity and Martech23.96%
Gaming & Entertainment16.26%
Quote time 2026-10-08 08:24:57 · For reference only, not investment advice and not tailored to your situation.